318 related articles for article (PubMed ID: 11747335)
1. RCAS1 as a tumour progression marker: an independent negative prognostic factor in gallbladder cancer.
Oshikiri T; Hida Y; Miyamoto M; Hashida H; Katoh K; Suzuoki M; Nakakubo Y; Hiraoka K; Shinohara T; Itoh T; Kondo S; Katoh H
Br J Cancer; 2001 Dec; 85(12):1922-7. PubMed ID: 11747335
[TBL] [Abstract][Full Text] [Related]
2. Expression of RCAS1 in esophageal squamous cell carcinoma is associated with a poor prognosis.
Kato H; Nakajima M; Masuda N; Faried A; Sohda M; Fukai Y; Miyazaki T; Fukuchi M; Tsukada K; Kuwano H
J Surg Oncol; 2005 May; 90(2):89-94. PubMed ID: 15844180
[TBL] [Abstract][Full Text] [Related]
3. p27(Kip1) expression in normal epithelia, precancerous lesions, and carcinomas of the gallbladder: association with cancer progression and prognosis.
Hui AM; Li X; Shi YZ; Torzilli G; Takayama T; Makuuchi M
Hepatology; 2000 May; 31(5):1068-72. PubMed ID: 10796881
[TBL] [Abstract][Full Text] [Related]
4. Expression of RCAS1 is significantly associated with the progression and prognosis of oral squamous cell carcinomas in Taiwan.
Tsai TC; Yu CH; Cheng SJ; Liu BY; Chen HM; Chiang CP
Oral Oncol; 2008 Aug; 44(8):759-66. PubMed ID: 18061525
[TBL] [Abstract][Full Text] [Related]
5. [Expressions of receptor-binding cancer antigen expressed on SiSo cells, vascular endothelial growth factor, and matrix metalloproteinase-9 in cervical carcinoma and correlation thereof with the invasion and metastasis of the cancerous tissues].
Liu R; Pu DM; Cheng YX; Yin L
Zhonghua Yi Xue Za Zhi; 2007 May; 87(19):1326-9. PubMed ID: 17727777
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of receptor-binding cancer antigen expressed on SiSo cells (RCAS1) expression in relation to cadherin expression in patients with colorectal carcinoma.
Tsujitani S; Saito H; Honboh T; Ataka M; Tanida T; Makino M; Ikeguchi M
Dis Colon Rectum; 2007 Aug; 50(8):1241-9. PubMed ID: 17429708
[TBL] [Abstract][Full Text] [Related]
7. Expression of IGF-I, IGF-II, and IGF-IR in gallbladder carcinoma. A systematic analysis including primary and corresponding metastatic tumours.
Kornprat P; Rehak P; Rüschoff J; Langner C
J Clin Pathol; 2006 Feb; 59(2):202-6. PubMed ID: 16443739
[TBL] [Abstract][Full Text] [Related]
8. Heparanase expression in gallbladder carcinoma and its correlation to prognosis.
Wu W; Pan C; Yu H; Gong H; Wang Y
J Gastroenterol Hepatol; 2008 Mar; 23(3):491-7. PubMed ID: 17524042
[TBL] [Abstract][Full Text] [Related]
9. Identification of immunohistochemical prognostic markers for survival after resection of pulmonary metastases from colorectal carcinoma.
Pfannschmidt J; Bade S; Hoheisel J; Muley T; Dienemann H; Herpel E
Thorac Cardiovasc Surg; 2009 Oct; 57(7):403-8. PubMed ID: 19795327
[TBL] [Abstract][Full Text] [Related]
10. Tumor-associated antigen recognized by the 22-1-1 monoclonal antibody encourages colorectal cancer progression under the scanty CD8+ T cells.
Oshikiri T; Miyamoto M; Morita T; Fujita M; Miyasaka Y; Senmaru N; Yamada H; Takahashi T; Horita S; Kondo S
Clin Cancer Res; 2006 Jan; 12(2):411-6. PubMed ID: 16428480
[TBL] [Abstract][Full Text] [Related]
11. Factors influencing recurrence after surgical treatment for T2 gallbladder carcinoma.
Aramaki M; Matsumoto T; Shibata K; Himeno Y; Yada K; Hirano S; Sasaki A; Kawano K; Kitano S
Hepatogastroenterology; 2004; 51(60):1609-11. PubMed ID: 15532788
[TBL] [Abstract][Full Text] [Related]
12. Lymphovascular invasion is an independent prognostic factor in prostatic adenocarcinoma.
Cheng L; Jones TD; Lin H; Eble JN; Zeng G; Carr MD; Koch MO
J Urol; 2005 Dec; 174(6):2181-5. PubMed ID: 16280760
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of Ki-67 and p53 antigen expression in carcinomas of bile duct and gallbladder.
Shrestha ML; Miyake H; Kikutsuji T; Tashiro S
J Med Invest; 1998 Aug; 45(1-4):95-102. PubMed ID: 9864969
[TBL] [Abstract][Full Text] [Related]
14. Protein and gene expression of tumor-associated antigen RCAS1 in esophageal squamous cell carcinoma.
Ikeguchi M; Ohoro S; Maeda Y; Yamaguchi K; Fukuda K; Shirai H; Kondo A; Tsujitani S; Kaibara N
Oncol Rep; 2003; 10(6):1891-4. PubMed ID: 14534714
[TBL] [Abstract][Full Text] [Related]
15. Expression of ezrin, HGF and c-met and its clinicopathological significance in the benign and malignant lesions of the gallbladder.
Yang L; Guo T; Jiang S; Yang Z
Hepatogastroenterology; 2012 Sep; 59(118):1769-75. PubMed ID: 22172411
[TBL] [Abstract][Full Text] [Related]
16. Gene and protein expression of RCAS1 in hepatocellular carcinoma.
Ikeguchi M; Hirooka Y; Kaibara N
Anticancer Res; 2003; 23(6D):4967-71. PubMed ID: 14981953
[TBL] [Abstract][Full Text] [Related]
17. Fascin overexpression correlates with positive thrombospondin-1 and syndecan-1 expressions and a more aggressive clinical course in patients with gallbladder cancer.
Roh YH; Kim YH; Choi HJ; Lee KE; Roh MS
J Hepatobiliary Pancreat Surg; 2009; 16(3):315-21. PubMed ID: 19259612
[TBL] [Abstract][Full Text] [Related]
18. Cdc2 as prognostic marker in stage UICC II colon carcinomas.
Meyer A; Merkel S; Brückl W; Schellerer V; Schildberg C; Campean V; Hohenberger W; Croner RS
Eur J Cancer; 2009 May; 45(8):1466-73. PubMed ID: 19223178
[TBL] [Abstract][Full Text] [Related]
19. p53 as a new prognostic factor for lymph node metastasis in penile carcinoma: analysis of 82 patients treated with amputation and bilateral lymphadenectomy.
Lopes A; Bezerra AL; Pinto CA; Serrano SV; de MellO CA; Villa LL
J Urol; 2002 Jul; 168(1):81-6. PubMed ID: 12050497
[TBL] [Abstract][Full Text] [Related]
20. Analysis of prognostic factors after surgery for stage III and IV gallbladder cancer.
Wakabayashi H; Ishimura K; Hashimoto N; Otani T; Kondo A; Maeta H
Eur J Surg Oncol; 2004 Oct; 30(8):842-6. PubMed ID: 15336729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
